Skip to Main Content

Alzheimer’s Association Funds Research at UMass Lowell


* M E D I A  A D V I S O R Y *

‘SmartPill’ Uses Vitamin Formulation to Improve Brain Health, Memory

Monday, Oct. 20, 2008
1:30 p.m.

WHAT:  Researchers at UMass Lowell have demonstrated success in improving the memory and brain function of patients with Alzheimer’s disease, findings that will be published in the December/January issue of the American Journal of Alzheimer’s Disease. The vitamin-based formulation also improved memory and recall speed in normal adults, without side effects.

The national Alzheimer’s Association is funding additional clinical trials to test whether the formulation can delay the onset of Alzheimer’s. The Massachusetts chapter president will present a check for $240,000 for three years to UMass Lowell Prof. Thomas Shea, the lead researcher. The “SmartPill” is in negotiations for a licensing agreement.

“This formulation is the first, non-prescription, low-cost intervention for Alzheimer’s disease,” says Shea, a Biology professor. “One can start this at the first indication of memory problems, or even before for general brain health, instead of waiting for the severe deterioration of advancing Alzheimer’s.”

Shea, representatives of the Alzheimer’s Association and UMass Lowell Chancellor Marty Meehan are among those scheduled to attend the event.

WHERE:  Allen House, Two Solomont Way, UML South, Lowell, Mass. Contact the Office of Public Affairs for directions and parking information.


For more information, contact or 978-934-3224